BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 8413755)

  • 1. [Cerebellar atrophy and phenytoin poisoning. An MR study].
    Luef G; Marosi M; Felber S; Birbamer G; Aichner F; Bauer G
    Nervenarzt; 1993 Aug; 64(8):548-51. PubMed ID: 8413755
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cerebellar atrophy following phenytoin intoxication.
    Lindvall O; Nilsson B
    Ann Neurol; 1984 Aug; 16(2):258-60. PubMed ID: 6476798
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phenytoin overdosage and cerebellar atrophy in epileptic patients: clinical and MRI findings.
    Luef G; Chemelli A; Birbamer G; Aichner F; Bauer G
    Eur Neurol; 1994; 34 Suppl 1():79-81. PubMed ID: 8001616
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cerebellar volume and long-term use of phenytoin.
    De Marcos FA; Ghizoni E; Kobayashi E; Li LM; Cendes F
    Seizure; 2003 Jul; 12(5):312-5. PubMed ID: 12810345
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cerebellar atrophy in an epileptic child: is it due to phenytoin?
    Ahuja SR; Karande S; Kulkarni MV
    J Postgrad Med; 2000; 46(4):278-9. PubMed ID: 11435657
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Temporal cerebellar atrophy following phenytoin therapy].
    Guerrero AL; Paniagua JA; Díaz Cascajo P; Cacho J; Arias P; Martín JA
    Neurologia; 1997; 12(6):259-61. PubMed ID: 9303595
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Cerebellar atrophy in epileptic patients: computer tomography study].
    Kessler C; Henningsen H; Reuther R; Christian W
    Fortschr Neurol Psychiatr; 1985 Dec; 53(12):437-41. PubMed ID: 4077007
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Magnetic resonance volumetry of the cerebellum in epileptic patients after phenytoin overdosages.
    Luef G; Burtscher J; Kremser C; Birbamer G; Aichner F; Bauer G; Felber S
    Eur Neurol; 1996; 36(5):273-7. PubMed ID: 8864707
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Dose-dependent relationship of chronic use of phenytoin and cerebellar atrophy in patients with epilepsy].
    Del Negro A; Dantas CD; Zanardi V; Montenegro MA; Cendes F
    Arq Neuropsiquiatr; 2000 Jun; 58(2A):276-81. PubMed ID: 10849627
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Folic-acid deficiency due to long-term anticonvulsant therapy as a causal factor of cerebellar degeneration (author's transl)].
    Meyer-Wahl L
    Nervenarzt; 1980 Oct; 51(10):619-22. PubMed ID: 6779215
    [No Abstract]   [Full Text] [Related]  

  • 11. [Phenytoin poisoning in a degradation disorder, report of a case with cerebellar atrophy].
    Feuerstein T; von Reutern GM; Cramer H
    Nervenarzt; 1983 Feb; 54(2):106-9. PubMed ID: 6405292
    [No Abstract]   [Full Text] [Related]  

  • 12. Cerebellar volumes in newly diagnosed and chronic epilepsy.
    Hagemann G; Lemieux L; Free SL; Krakow K; Everitt AD; Kendall BE; Stevens JM; Shorvon SD
    J Neurol; 2002 Dec; 249(12):1651-8. PubMed ID: 12529786
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Plasma separation in acute, intravenous phenytoin poisoning].
    Scharf J; Ruder H; Harms D
    Monatsschr Kinderheilkd; 1990 Apr; 138(4):227-30. PubMed ID: 2113180
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Cerebellar atrophy and persistent cerebellar ataxia after acute intoxication of phenytoin].
    Imamura T; Ejima A; Sahara M; Saito H; Tsuburaya K
    No To Shinkei; 1992 Feb; 44(2):149-53. PubMed ID: 1567734
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proton magnetic resonance spectroscopic imaging in patients with cerebellar degeneration.
    Tedeschi G; Bertolino A; Massaquoi SG; Campbell G; Patronas NJ; Bonavita S; Barnett AS; Alger JR; Hallett M
    Ann Neurol; 1996 Jan; 39(1):71-8. PubMed ID: 8572670
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Diphenylhydantoin intoxication following the exchange of seemingly equal DPH-preparations (author's transl)].
    Klingler D; Nitsche V; Schmidbauer H
    Wien Med Wochenschr; 1981; 131(11):295-300. PubMed ID: 6789561
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cerebellar atrophy does not increase susceptibility to carbamazepine toxicity.
    Specht U; Rohde M; May T; Schmidt RC; Meencke HJ; Wolf P
    Acta Neurol Scand; 1994 Jan; 89(1):1-4. PubMed ID: 8178620
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ADC mapping of neurodegeneration in the brainstem and cerebellum of patients with progressive ataxias.
    Della Nave R; Foresti S; Tessa C; Moretti M; Ginestroni A; Gavazzi C; Guerrini L; Salvi F; Piacentini S; Mascalchi M
    Neuroimage; 2004 Jun; 22(2):698-705. PubMed ID: 15193598
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical significance of serum phenytoin level].
    Oettinger B; Richter K
    Psychiatr Neurol Med Psychol (Leipz); 1978 Jul; 30(7):424-9. PubMed ID: 100799
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Single daily dose of diphenylhydantoin in treating epilepsy].
    Shen DL
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1985 Jun; 18(3):145-7. PubMed ID: 3932025
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.